A charge-dependent mechanism is responsible for the dynamic accumulation of proteins inside nucleoli  by Musinova, Yana R. et al.
Biochimica et Biophysica Acta 1853 (2015) 101–110
Contents lists available at ScienceDirect
Biochimica et Biophysica Acta
j ourna l homepage:  www.e lsev ier .com/ l ; ocate/bbamcrA charge-dependent mechanism is responsible for the dynamic
accumulation of proteins inside nucleoliYana R. Musinova a, Eugenia Y. Kananykhina b, Daria M. Potashnikova c, OlgaM. Lisitsyna b, Eugene V. Sheval a,⁎
a Belozersky Institute of Physico-Chemical Biology, Lomonosov Moscow State University, Moscow 119991, Russia
b Department of Bioengineering and Bioinformatics, Lomonosov Moscow State University, Moscow 119991, Russia
c Department of Cell Biology and Histology, Lomonosov Moscow State University, Moscow 119991, RussiaAbbreviations:NoLS, nucleolar localization signal; iNo
tion signal; NIK, NF-κB-inducing kinase; S.D., standart devi
ery after photobleaching; BiFC, bimolecular ﬂuorescence co
⁎ Corresponding author. Tel.: +7 4959395528.
E-mail address: sheval_e@belozersky.msu.ru (E.V. She
http://dx.doi.org/10.1016/j.bbamcr.2014.10.007
0167-4889/© 2014 Elsevier B.V. All rights reserved.a b s t r a c ta r t i c l e i n f oArticle history:
Received 16 June 2014
Received in revised form 2 October 2014
Accepted 6 October 2014





B23The majority of known nucleolar proteins are freely exchanged between the nucleolus and the surrounding
nucleoplasm. One way proteins are retained in the nucleoli is by the presence of speciﬁc amino acid sequences,
namely nucleolar localization signals (NoLSs). Themechanism bywhich NoLSs retain proteins inside the nucleoli
is still unclear. Here, we present data showing that the charge-dependent (electrostatic) interactions of NoLSs
with nucleolar components lead to nucleolar accumulation as follows: (i) knownNoLSs are enriched in positively
charged amino acids, but theNoLS structure is highly heterogeneous, and it is not possible to identify a consensus
sequence for this type of signal; (ii) in two analyzed proteins (NF-κB-inducing kinase and HIV-1 Tat), the NoLS
corresponds to a region that is enriched for positively charged amino acid residues; substituting charged
amino acids with non-charged ones reduced the nucleolar accumulation in proportion to the charge reduction,
and nucleolar accumulation efﬁciencywas strongly correlatedwith the predicted charge of the tested sequences;
and (iii) sequences containing only lysine or arginine residues (which were referred to as imitative NoLSs, or
iNoLSs) are accumulated in the nucleoli in a charge-dependent manner. The results of experiments with iNoLSs
suggested that charge-dependent accumulation inside the nucleoliwas dependent on interactionswith nucleolar
RNAs. The results of this work are consistent with the hypothesis that nucleolar protein accumulation by NoLSs
can be determined by the electrostatic interaction of positively charged regions with nucleolar RNAs rather than
by any sequence-speciﬁc mechanism.
© 2014 Elsevier B.V. All rights reserved.1. Introduction
The cellular nucleus is a highly compartmentalized organelle con-
taining numerous domains and bodies that lack deﬁning membranes
(for a recent review, see: [1]). Nuclear organelles are relatively macro-
scopically stable and can be observed for hours by light microscopy in
living cells. However, despite this stability, nuclear substructures may
be highly dynamic at the molecular level [2]. Using photobleaching/
activation techniques, the majority of nuclear proteins examined to
date have been shown to behighlymobile: these proteins diffuse rapidly
within the nucleoplasm and typically exchange quickly with their
binding sites [3,4].
In the absence of a delineating lipid boundary to distinguish nuclear
bodies from their environment and given the ongoingprotein exchange,
key questions remain as to how macromolecules ﬁnd their target sites
inside the nucleus and how they accumulate in these target sites [5].LS, imitative nucleolar localiza-
ation; FRAP,ﬂuorescence recov-
mplementation
val).The ability of proteins to diffuse rapidly through the nucleus sug-
gests that molecules locate their target sites through random three-
dimensional scanning of the nuclear space [6,7]. The ability of proteins
to accumulate inside nuclear bodies that are not separated from the nu-
cleoplasm by membranes is largely determined by transient interac-
tions with the components of these bodies. In particular, it is widely
believed that the accumulation of proteins inside nucleoli results from
high-afﬁnity binding interactions with core nucleolar components,
such as ribosomal DNA, RNAs and major protein components [8].
The nucleolus, the most prominent structure within eukaryotic
nuclei, is known primarily for its role in pre-ribosomal RNA (pre-
rRNA) transcription, processing and assembly with ribosomal proteins
to form pre-ribosomal subunits [9–13]. The nucleolus is also involved
in additional cellular functions, including the assembly of diverse
ribonucleoprotein particles, cell cycle regulation and the cellular stress
response [12,14–16].
According to the published data, speciﬁc signals known as nucleolar
localization signals (NoLSs) facilitate the accumulation of certain
proteins in the nucleoli. Themechanism bywhich NoLSs retain proteins
inside the nucleoli remains unknown [17]. A common mechanism
shared by most, if not all, NoLSs involves a stretch of positively charged
residues that permits NoLS accumulation in the nucleolus [18].We have
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that the nucleolar accumulation efﬁciency depends on the charge of
this NoLS [19]. We proposed that NoLSs can achieve their function
through electrostatic interactions with the negatively charged compo-
nents of the nucleoli. The nucleolar localization of plant ribosomal
protein RPL23aA was shown to depend on the overall basic charge
[20]. Positively charged polymers, FITC-labeled deca-arginine peptides
[21] and positively charged FITC-poly-L-lysines [22] accumulate inside
the nucleoli of living cells. All these data are consistent with the
idea that nucleolar protein accumulation may be dependent on
charge-dependent (electrostatic) interactions with certain nucleolar
components. However, this evidence is not conclusive.
The data on nucleolar components with which NoLSs interact are
highly contradictory. NoLSs have been shown to interact with certain
nucleolar proteins, speciﬁcally B23 (nucleophosmin, NPM1) [23–26]
or nucleolin and ﬁbrillarin [27]. Additionally, the artiﬁcial B23-binding
sequence has been described, and its properties are similar to the prop-
erties of NoLSs [28]. B23 [29,30], nucleolin [29] and ﬁbrillarin [29,31]
have been shown to be highly mobile proteins that permanently cycle
between the nucleolus and nucleoplasm in interphase cells. Therefore,
these nucleolar proteinsmay act only as receptors or as import machin-
ery for NoLSs. In contrast, the nucleolar accumulation of ribosomal
protein L22 was shown to be linked to its ability to bind RNA [32]. The
RNA-binding domain of L22 has not yet been identiﬁed, but clusters
of basic amino acids contribute to RNA binding and nucleolar localiza-
tion [32]. Some data indicate that both mechanisms are possible,
i.e., interactions with nucleolar proteins and with nucleolar RNA.
Apurinic/apyrimidinic endonuclease 1 (APE1) interacts with both
rRNA and B23, and this interaction depends strictly on the positive
charge of the K residues within APE1 region 24-35 in the N-terminal
domain [33,34]. This short domain is similar to known NoLSs. Further-
more, the NoLS of human ribosomal protein S9 resides inside a highly
conserved domain corresponding to a ribosomal RNA-binding site [35].
Interestingly, this ribosomal protein also contains two binding sites for
B23, but they do not overlap with NoLSs [35].
Here, we examined the hypothesis of a charge-dependent (electro-
static) mechanism of nucleolar retention via NoLSs. We were able to
demonstrate a strong correlation between the charge of a protein
fragment tested as a NoLS and its ability to accumulate marker protein
(EGFP) in the nucleoli. The results of experiments suggested that
charge-dependent accumulation inside the nucleoli was dependent on
interactions with nucleolar RNAs. This mode of accumulation is essen-
tially different from the accumulation of various other signals (which
include a nuclear localization signal, a signal sequence formitochondrial
import and an endoplasmic reticulum signal sequence, among others)
that achieve their activity by interacting with speciﬁc proteins.
2. Materials and methods
2.1. Plasmids
We used the following vectors for molecular cloning: pEGFP-C1 and
pEYFP-C1 (Clontech), pGEX-6p-1 (GE Healthcare) and pTagRFP-N1
(Evrogen). The B23-encoding plasmid was provided by X. Wang via
Addgene (plasmid 17578) [36]; the construction of the ﬁbrillarin-
TagRFP plasmid was described elsewhere [37].
To obtain nucleolar-targeting fusion proteins, the oligonucleotides
(Supplementary Table S1) were annealed and ligated into a HindIII-
and BamHI-digested pEGFP-C1 vector (Clontech). To obtain the B23-
TagRFP plasmid, full-length B23was PCR ampliﬁedwith Pfu polymerase
(Fermentas) using the following oligonucleotides: 5′-ATATGGATCCAA
GTTCTTCACCTTGGGGGGTG-3′ and 5′-TATATAAGCTTGACCATGAAGC
CAGGATTCAGTC-3′. The ampliﬁed PCR product was digested with
BamHI and HindIII and inserted into the pTagRFP-N1 vector (Evrogen).
After cloning into expression vector, the correctness of all constructs
was conﬁrmed by sequencing.2.2. Cell culture and transfection
HeLa cells were grown in Dulbecco's modiﬁed Eagle's medium
supplemented with L-glutamine, 10% fetal calf serum (HyClone)
and antibiotic/antimycotic solution (Sigma). Cellular transfection was
performed using TurboFect reagent (Fermentas) according to the
manufacturer's instructions.
To inhibit RNA transcription, the cells were grown in amediumwith
0.1 μg/ml or 20 μg/ml actinomycin D for 4 h. To induce interphase
prenucleolar body formation, the cells were incubated in 20% Hank's
balanced salt solution for 15min and then transferred into the complete
culture medium for 30 min [38]. A high-salt extraction was performed
as previously described [39].
2.3. Measurement of nucleolar accumulation efﬁciency
To evaluate the nucleolar accumulation efﬁciency, themean ﬂuores-
cence intensity in the nucleolus and the mean ﬂuorescence intensity in
the nucleoplasm as a measure of protein concentration for each fusion
protein were measured. This ratio of nucleolar EGFP concentration to
nucleoplasmic EGFP concentration was previously referred to as NoLS
activity [19]. Images of at least 50 living cells expressing nucleolar-
targeting fusion proteins were acquired in two different experiments
using an LSM510 confocal laser scanning microscope (Carl Zeiss). Cells
expressing different proteins were imaged under identical conditions
in all experiments. The regions of interest in the nucleolus and in the
nucleoplasmwere selectedmanually, and themean intensity of ﬂuores-
cence was measured using ImageJ software (http://rsbweb.nih.gov/ij/).
STATISTICA 6.0 software (StatSoft Inc.) was used for regression analysis.
2.4. Fluorescence recovery after photobleaching (FRAP)
For the FRAP experiments, the cells were grown in 35 mm dishes
containing coverslips. Themediumwas overlaid withmineral oil before
the experiment, and the dishesweremounted onto an LSM510 confocal
microscope (Carl Zeiss). The cells weremaintained at 37 °C using both a
lens heater (Bioptech) and a stage heater (Carl Zeiss). Four single scans
were acquired for the FRAP experiments, followed by a single pulse to
photobleach. The recovery curves were generated from background-
subtracted images. The relative ﬂuorescence intensity (RFI) was calcu-
lated as RFI = T0It/TtI0, where T0 was the total cellular intensity during
prebleaching, Tt was the total cellular intensity at time point t, I0 was
the average intensity in the region of interest during prebleaching,
and It was the average intensity in the region of interest at time point t.
2.5. Immunoﬂuorescence and image acquisition of ﬁxed cells
Cells were ﬁxed in 3.7% paraformaldehyde for 15 min. Fluores-
cence in situ hybridization was performed as described by Shishova
et al. [40]. The biotin-labeled oligonucleotide 5′-CCCGTTCCCTTGGC
TGTGGTTTCGCTAGATA-3′ that was used for staining 28S rRNA was
detected with streptavidin-Alexa555 (Invitrogen). The preparations
were observed with an Axiovert 200M microscope (Carl Zeiss)
equipped with an Apochromat 100×/1.4 oil immersion objective.
Stacks of images were recorded using an ORCAII-ERG2 cooled CCD
camera (Hamamatsu), and deconvolution was performed using Axiovi-
sion 3.1 software (Carl Zeiss). For contrast/brightness correction and
ﬁnal presentation, all images were transferred into Adobe Photoshop
CS2 (Adobe Systems).
2.6. Immunoblotting
Cells grown in 30 mm culture dishes were lysed in Laemmli sample
buffer, boiled for 3min, resolved on a 12.5% SDS-polyacrylamide gel and
transferred to a nitrocellulose membrane (Sigma). The membranes
were blocked in 1% bovine serum albumin and incubated with primary
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against GFP (1:3000; a generous gift from A.G. Evstaﬁeva), monoclonal
antibody against B23 (1:10,000; Sigma) and monoclonal antibody
against β-tubulin (1:10,000; Sigma). The membranes were washed
in three changes of PBS (5 min each) and were then incubated with
secondary peroxidase-conjugated antibody (1:15,000; Sigma). The
antibody-bound proteins were detected using Pierce ECL Western
Blotting Substrate (Thermo Scientiﬁc) and acquired using a Gel Doc
XR system (BioRad).2.7. shRNA-mediated B23 depletion
We used a pGreenPuro shRNA cloning and expression system
(SystemBiosciences) for B23 depletion. The shRNA probe for B23
was described by Liu and coauthors [41]. The anti-parallel sequence
was used as a control. The oligonucleotides encoding shRNA (Supple-
mentary Table S2) were annealed and ligated into a pGPV vector
(SystemBiosciences).
Cells expressing copGFP were collected using a FACSAria SORP cell
sorter (BD Biosciences). The excitation wavelength for GFP was
488 nm, and the emission was detected by a 505LP and 515/20BP set
of ﬁlters. Sorting was performed with an 85 μmnozzle and correspond-
ing custom pressure parameters. The sorted cells were then cloned, and
the clones with the lowest level of B23 expression were selected by
immunoblotting.2.8. EGFP and EGFP-R19 expression, puriﬁcation and interaction with
permeabilized cells
EGFP was PCR ampliﬁed with Pfu polymerase (Fermentas) using
the following oligonucleotides: 5′-CTGGGATCCATGGTGAGCAAGGGC
GAGGAG-3′ and 5′-ACTGGTCGACCTGATTATGATCAGTTATCTAGATCC
GGT-3′. EGFP-R19 was ampliﬁed using the following oligonucleotides:
5′-CTGGGATCCATGGTGAGCAAGGGCGAGGAG-3′ and 5′-ATATGTCGAC
TCACTTGTACAGCTCGTCCATGCCG-3′. The PCR products were digested
with BamHI and SalI and cloned into a pGEX-6p-1 vector (GE
Healthcare). EGFP and EGFP-R19 were expressed in Escherichia coli
Rosetta (DE3), and the corresponding proteins were puriﬁed with
Glutathione-Sepharose 4B and PreScission Protease (Amersham) as
recommended by the manufacturer.
HeLa cells grown in a μ-Slide ﬂow chamber (Ibidi) were perme-
abilized in buffer containing 50 mM Tris–HCl (pH 7.6), 150 mM NaCl,
0.5% Triton X-100 and protease inhibitor cocktail (Sigma) for 5 min at
4 °C. After permeabilization, the cells were washed three times with
the same buffer without Triton X-100 (washing buffer) and, if neces-
sary, treatedwith RNase A (10 μg/ml; Sigma) for 5min at room temper-
ature. After washing, the cells were incubated in washing buffer
containing 50 μg/ml of either EGFP or EGFP-R19 for 15 min at 4 °C.
After washing, the cells were photographed using an Axiovert 200M
microscope equipped with a Neoﬂuar 40/0.75 objective.2.9. Bimolecular ﬂuorescence complementation (BiFC)
The primers that were used for the construction of B23 fusions with
the N-terminal half of YFP (nYFP) or the C-terminal half of YFP (cYFP)
are presented in Supplementary Table S3. n/cYFP-R19 plasmids were
obtained using the same adapter that was used for the construction of
EGFP-R19 (Supplementary Table S1). The cotransfection of plasmids
was performed with Lipofectamine 2000 reagent (Invitrogen) accord-
ing to the manufacturer's recommendations. The images of living cells
were acquired 24 h after transfection with an Axiovert 200M micro-
scope (Carl Zeiss) equipped with a Neoﬂuar 100/1.3 oil immersion
objective.3. Results
3.1. Known NoLSs are enriched in positively charged amino acids
Many proteins containing nucleolar localization signals (NoLSs)
have been described. The available data on known NoLSs are summa-
rized in Supplementary Table S4. There are 21 known NoLSs in 20
viral proteins, 64 NoLSs in 58 animal proteins, 1 NoLS in a plant protein
and 1 NoLS in a fungal protein. In addition, there are three synthetic se-
quences that can accumulate EGFP in the nucleoli and thus demonstrate
the characteristic properties of NoLSs [19,28]. NoLSs are enriched with
either lysine or arginine residues; however, the NoLS primary structure
is highly heterogeneous. There are NoLSs in which the lysines and
arginines are distributed as compact clusters and others where they
alternate with non-charged amino acids (Fig. 1A). We could not ﬁnd a
consensus for these sequences, but the consensus sequence RRR-RKR-
R was found for a smaller sampling of NoLSs in Reed et al. [46]. An anal-
ysis of a complete sampling of known NoLSs (Supplementary Table S4)
demonstrates that this consensus is, at best, only a special case within
the highly heterogeneous group of sequences.
NoLSs contain 3 to 50 amino acids (mean— 18 amino acids), and they
are predominantly localized at the N- or C-termini of animal proteins or
at the N-termini of viral proteins (Fig. 1B). An analysis of folded and
unfolded protein regions by FoldIndex software predicted that the vast
majority of NoLSs (all viral NoLSs and 55 of 64 animal NoLSs) are
fragments of intrinsically disordered regions (Supplementary Table S4).
A common feature of all described NoLSs is their enrichment in
positively charged amino acids, namely lysines and arginines. Whereas
proteins in general contain an average of approximately 15% positively
charged amino acids, theNoLSs contain approximately 50%. Interesting-
ly, viral proteins and NoLSs from viral proteins contain slightly more
arginines than lysines, while animal proteins and NoLSs exhibit the
opposite ratio (Fig. 1C). Because of this amino acid content, all NoLSs
have a positive charge (Supplementary Table S4).
Thus, to our knowledge, a positive charge is the single common
feature for all known NoLSs. It is possible that the mechanism of NoLS
action depends not on the amino acid sequence but only on the enrich-
ment with positively charged amino acids.
3.2. Nucleolar accumulation depends on the presence of positively charged
amino acids
We propose that charge-dependent interactions determine the
accumulation of proteins in nucleoli. In this case, the NoLSs would
correspond to regions that are enriched for positively charged amino
acid residues. Thus, replacement of charged lysines and arginines with
non-charged amino acids would reduce nucleolar accumulation in a
charge-dependent manner. Interestingly, positively charged amino
acids are often found in regions ﬂanking known NoLSs; thus, it is likely
that these amino acids enhance theNoLS action and non-charged amino
acidsﬂanking the knownNoLSs do not affect nucleolar accumulation. To
test these hypotheses, we analyzed the structure of the NoLSs in two
proteins, namely NF-κB-inducing kinase (NIK) and HIV-1 Tat. The
NoLSs of both these proteins contain a compact group of seven positive-
ly charged amino acids, but their ﬂanking regions are different.
There are several positively charged amino acids in NIK near the
NoLS [43]. To ascertain whether these amino acids might contribute to
nucleolar localization, we constructed plasmids encoding EGFP fused
with the NIK NoLS or the NoLS with different numbers (2, 4, 6, or 8) of
proximal amino acids (Fig. 2A). The NoLS activity (the EGFP concentra-
tion in the nucleoli/the EGFP concentration in the nucleoplasm) was
measured for all fusions to evaluate the effect of additional amino
acids on nucleolar accumulation (Supplementary Table S5). The NoLS
extension at the N-terminus, where there are several positively charged
amino acids, led to a signiﬁcant increase in NoLS activity (Fig. 2B).
Extending the C-terminus did not signiﬁcantly affect accumulation.
Fig. 1. Characteristics of NoLSs as described in published works. (A) Four NoLSs with different structures, as follows: NoLS from FXR2 [42] is enrichedwith arginines, while NoLS from NF-
κB-inducing kinase [43] enrichedwith lysines, distributed in both cases as compact clusters; NoLSs fromBICP27 [44] and ribosomal protein S7 [45] contain positively charged amino acids
alternating with non-charged amino acids. Positively charged amino acids are marked in red. (B) NoLSs are predominantly found at the ends of proteins (at the N- or C-termini of the
animal proteins or at the N-termini of viral proteins). (C) The average amino acid content of known NoLSs from viruses and animals (left panels) in comparison with the overall amino
acid content of the proteins (right panels).
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(R = 0.979, p = 0.000005).
Replacing the lysine or arginine residues with glycinewithin the de-
scribed NoLS reduced the accumulation of proteins in the nucleolus
(Fig. 2C and Supplementary Table S6). The replacement of two or
three charged amino acids led to a stronger reduction in NoLS activity,
and in general, the effect was proportional to the number of charged
amino acids that had been replaced (i.e., proportional to the reduction
in charge). NoLS activity correlated with the predicted charge (R =
0.949; p b 0.000001), as in a prior experiment.
In the case of HIV-1 Tat protein, the describedNoLS (GRKKRRQRRSAP)
includes several non-charged amino acids at the N- and C-termini [47].
These amino acids did not signiﬁcantly enhance NoLS activity (Fig. 2D, E
and Supplementary Table S7). Other surrounding non-charged amino
acids did not exert any strong effects on NoLS activity, as described
above for positively charged amino acids at the N-terminus of NIK. Thus,
the NoLS in HIV-1 Tat protein corresponds to a region that is enriched
for positively charged amino acid residues.
The replacement of positively charged amino acids inside the HIV-1
Tat NoLS led to a decrease in the accumulation efﬁciency (Fig. 2F and
Supplementary Table S8). The replacement of non-charged glutamine(amino acid no. 6 in Fig. 2F) inside this NoLS did not affect the NoLS ac-
tivity. As in the case of NIK, the HIV-1 Tat NoLS activity correlated with
the charge of the tested region (R = 0.915; p = 0.000002).
3.3. The iNoLS accumulation in the nucleoli correlateswith the charge of the
amino acid sequence and the clustering of the charged amino acids
We previously noted that short clusters of positively charged
amino acids, which were referred to as imitative NoLS (iNoLS),
are able to accumulate EGFPs inside nucleoli [19]. Here, we used
this model to investigate the role of charge in nucleolar protein
accumulation.
We analyzed the nucleolar accumulation of EGFP fused with differ-
ent numbers of lysines or arginines (Supplementary Table S9). Nucleo-
lar accumulation (i.e., NoLS activity N 1) was observed for all iNoLS
containing more than three arginines or ﬁve lysines (Fig. 3A, B). A
higher charge led to a more pronounced nucleolar accumulation
of EGFP. The NoLS activity correlated with the predicted charge
of the fused stretches (iNoLSs containing arginines: R = 0.988,
p b 0.000001; iNoLSs containing lysines: R = 0.979, p = 0.000001).
The NoLS activity was slightly higher for arginine-containing iNoLS
Fig. 2.Mapping amino acids that are important for nucleolar accumulation via NoLSs in two proteins (NIK and HIV-1 Tat). (A) The amino acid sequences used tomapNoLSmargins inNIK.
Positively charged amino acids are marked in red, and negatively charged ones aremarked in blue. (B) The NoLS activities of the regions presented in Fig. 2A. (C) Replacement of charged
amino acids decreased the activity of theNoLS inNIK. (D) The amino acid sequences used formappingNoLSmargins inHIV-1Tat. (E) TheNoLS activities of the regions presented in Fig. 2D.
(F) Replacement of charged amino acids decreased the activity of the NoLS in HIV-1 Tat. In Figures B, C, E and F, the error bars represent standard deviation (S.D.).
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plained by the different properties of these amino acids. In fact, the pI of
arginine-containing iNoLSs was slightly higher than the pI of lysine-
containing ones (Supplementary Table S9); therefore, the former tags
would be slightly more positively charged than the latter ones under
physiological conditions.
Themore pronounced nucleolar accumulationwas correlatedwith a
decreased rate of EGFP exchange between the nucleoli and surrounding
nucleoplasm, as determined using the ﬂuorescence recovery after
photobleaching (FRAP) method (Fig. 3C). These data indicate that theFig. 3. Positively charged iNoLSs accumulate EGFP in the nucleoli in a charge-dependent mann
accumulate EGFP in the nucleoli with different efﬁciencies, which correlate with the predict
arginines (left panel) or lysines (right panels). (C) The dynamics of iNoLS-containing fusions (F
if the charged amino acid residues in the iNoLS are distributed as a compact cluster. In Figuresenhanced nucleolar accumulation was caused by dynamic retention
rather than EGFP immobilization on nucleolar components.
One can assume that the nucleolar accumulation would depend not
only on the iNoLS charge but also on the clustering of the positively
charged amino acids. To conﬁrm this hypothesis, we constructed pairs
of iNoLSs inwhich six or nine charged amino acids (arginines or lysines)
were located either in the form of a block or alternating with non-
charged amino acids. The nucleolar accumulation was signiﬁcantly
higher when the charged amino acids were clustered (Fig. 3D and
Supplementary Table S10).er. (A) The iNoLSs with different numbers of arginines (top row) or lysines (bottom row)
ed charges of the sequences. (B) The NoLS activities of different iNoLS containing either
RAP analysis). Each FRAP curve is an average of 10–12 cells. (D) The NoLS activity is higher
B and D, the error bars represent S.D. Scale bars = 5 μm.
Fig. 4. The localization of EGFP-R19 is similar to the localization of nucleolar protein B23. (A) In interphase nuclei, EGFP-R19 exhibits localization similar to the localization of B23 but not
ﬁbrillarin. (B) FRAP analysis of EGFP-R19 dynamics. Images are shown with intensity pseudocolors. The contrast was adjusted in the last frame to normalize for the loss of ﬂuorescence
during imaging. The FRAP curve is an average of 15 cells (mean ± S.D.). (C) After treatment with 0.1 μg/ml actinomycin D, the nucleolar components were segregated, and EGFP-R19
was preferentially localized in the B23-containing regions. (D) EGFP-R19 colocalized with B23 in mitotic cells. The perichromosomal layer is indicated by arrows, and the prenucleolar
bodies of telophase cells are indicated by arrowheads. (E) EGFP-R19 bound with interphase prenucleolar bodies (arrowheads), which formation was induced by hypotonic treatment.
(F) EGFP-19 is not a component of the nuclear matrix, in contrast with B23-TagRFP. Top panels: cells after permeabilization; bottom panels: cells after 2 M NaCl extraction. The
cells were registered under identical conditions, and the images were processed identically. (G) EGFP-19 is not a component of the nuclear matrix, in contrast to B23 (immunoblotting).
P - permeabilization, NM - nuclear matrix (extraction). Scale bars = 5 μm.
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amino acid content of known NoLSs and experiments with NoLSs of
NIK and HIV-1 Tat, are consistent with the idea of a charge-dependent
(electrostatic) mechanism of protein accumulation inside nucleoli.
3.4. EGFP-R19 is a suitable model for studying the mechanisms
of NoLS action
The nucleolus consists of several structural components [48] and
containsmany different proteins [49]. Nucleolar proteins can be divided
into several groups based on their varied localization and their behavior
in experimental models. For example, nucleolar proteins that partici-
pate in the early stages of pre-rRNA processing, such as ﬁbrillarin, arelocalized in the dense ﬁbrillar component [50], and proteins that are
involved in late stages of processing, such as B23, are localized in the
granular component [51]. The difference in localization is clearly seen
in actinomycin D-treated nucleoli, in which ﬁbrillarin localizes in the
caps of the nucleolus, whereas B23 localizes in the central body and
outside the caps [52].
The iNoLSs with the highest numbers of positively charged amino
acids (i.e., R19) exhibited signiﬁcantly higher NoLS activity than the
NoLSs from the HIV-1 Tat and NIK proteins studied here. If the proper-
ties of EGFPs fusedwith iNoLS are similar to the properties of certain nu-
cleolar proteins then it is possible that the iNoLSs with the highest
efﬁciency of nucleolar accumulation would be a useful model for study-
ing the mechanisms of NoLS action.
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localization of B23 protein. Speciﬁcally, (i) EGFP-R19 was colocalized
with B23-TagRFP but not with ﬁbrillarin-TagRFP in the interphase nu-
cleoli (Fig. 4A), i.e., it was preferentially localized in the granular compo-
nent of the nucleoli. (ii) We used the FRAP method to study EGFP-R19
dynamics in the nucleoli. EGFP-R19 was highly dynamic, and the half
time (t1/2) of ﬂuorescence recovery in the nucleoli was ~20 s (Fig. 4B).
(iii) After the inhibition of pre-rRNA transcription by 0.1 mg/ml actino-
mycin D, the nucleolar components were segregated, and EGFP-R19
was preferentially localized in the compartment containing B23-
TagRFP but not in the compartment containing ﬁbrillarin-TagRFP
(Fig. 4C). (iv) In addition,we analyzed the distribution of EGFP-R19dur-
ing mitosis by using cells that coexpressed EGFP-R19 and B23-TagRFP
(Fig. 4D). The relocation of EGFP-R19 during mitosis was, in general,
similar to the relocation of B23, although EGFP-R19 was not observed
in the perichromosomal layer of anaphase chromosomes, where B23
was easily detected. (v) After hypotonic treatment and subsequent
incubation in complete culturemedium, interphase prenucleolar bodies
containing B23 formed in the nucleoplasm [38]. EGFP-R19 was also
localized inside these bodies (Fig. 4E).
EGFP-R19 demonstrated a localization pattern that was quite similar
to the localization of B23, but the properties of EGFP-R19 and B23 were
not all identical. For example, B23 is a component of the nuclear matrix
[53], but EGFP-R19was not found in the nuclearmatrix (Fig. 4, F and G).
The data presented here indicate that EGFP-R19 is a suitable model
for studying the mechanisms of NoLS action. The advantage of this re-
porter protein is that it does not engage in themultitude of interactions
that have been observed for B23 or other nucleolar proteins. Here, we
used this iNoLS to examine the nucleolar components with which
NoLSs interact through a charge-dependent mechanism.
3.5. The nucleolar localization of pEGFP-R19 is RNA-dependent
Published data indicate that the NoLSs of different proteins interact
either with RNA [32] or with the nucleolar proteins — B23, ﬁbrillarin
or nucleolin [23–27]. These results do not exclude the electrostatic
mechanism of NoLS interaction, as RNA is a negatively charged
molecule, and B23 and nucleolin contain lengthy acidic stretches.
We have studied both possible mechanisms, namely interaction
with RNA orwith nucleolar proteins.Weparticularly focused onB23be-
cause the majority of the paper suggested interaction with this protein
[23–26]. To test this, we decreased the nucleolar RNA or B23 content
using transcription inhibitors or RNA interference, respectively. It is
likely that decreasing the component with which the iNoLS interacts
would inﬂuence the localization of EGFP-R19.
To ascertain whether the destruction of RNA in vivo leads to the
destruction of EGFP-R19 and B23 interactions, we have incubated cells
expressing EGFP-R19 in the presence of 20 μg/ml of actinomycin D for
4 h. This treatment totally inhibited RNA transcription (Fig. 5A), but
the B23 content in these cells was not signiﬁcantly changed (Fig. 5B).
We used cells transiently transfected with plasmid coding EGFP-R19,
and we observed no difference in EGFP-R19 localization depending on
the content of this protein. For image acquisition, the cells with a
moderate level of EGFP-R19 expression were selected both in control
and actinomycin D-treated cells.
We previously observed that this treatment led to the total destruc-
tion of nucleoli [53]. After actinomycin D treatment, EGFP-R19 was
removed from the nucleoli to the nucleoplasm, indicating that nucleolar
accumulation of this protein correlated with nucleolar integrity
(Fig. 5C). EGFP-R19 was distributed in the nucleoplasm and in nucleo-
plasmic bodies formed de novo (Fig. 5C). EGFP was not accumulated in-
side these nucleoplasmic bodies (Supplementary Figure S1). To reveal
the localization of RNA in these cells, the cells were preincubated with
5-ethynyl uridine (EU) for 1 h before adding actinomycin D. The RNA
was distributed in the nucleoplasm and concentrated in EGFP-R19-
containing nucleoplasmic bodies (Fig. 5C). These bodies were labeledwith the 28S rRNA-speciﬁc hybridization probe (Supplementary
Figure S2). Importantly, B23 was distributed in the nucleoplasm, and
it was not colocalized with EGFP-R19 inside the nucleoplasmic bodies
(Fig. 5D), indicating that EGFP-R19 interacts with RNA rather than
with B23. In addition, nucleolin and ﬁbrillarin were not accumulated
inside these bodies (Supplementary Figure S3).
We then studied the effect of B23 depletion by RNA interference on
EGFP-R19 localization. HeLa cells expressing a plasmid encoding B23-
speciﬁc shRNA were used. The B23 content of these cells was signiﬁ-
cantly reduced (Fig. 5E). Because these cells coexpressed copGFP, we
used mCherry-R19 to study iNoLS localization. Similar to cells express-
ing the control shRNA, mCherry-R19 was localized in the nucleoli
(Fig. 5F). The NoLS activity of mCherry-R19 was similar in the control
cells, in cells expressing the control shRNA and in cells expressing B23
shRNA.
In addition, we studied the in situ binding of puriﬁed EGFP and
EGFP-R19 with permeabilized cells (Fig. 5G). EGFP-R19 interacted
with both the control cells and with the actinomycin D-treated cells.
EGFP-R19 was distributed in the nucleoli in control cells and in the
nucleoplasm and in nucleoplasmic bodies in the treated cells (Supple-
mentary Figure S4). Binding was signiﬁcantly reduced in cells treated
with RNase A, but EGFP-R19 interacted with the nucleoli of B23-
depleted cells. The EGFP used as a control did not interact with the
permeabilized cells.
The results of in vivo and in situ experiments suggest that EGFP-R19
interacts with RNA rather than B23. However, (i) the distribution
of RNA was not identical to the EGFP-R19 distribution (Fig. 5C), and
(ii) EGFP-R19 was colocalized with B23 in the control cells (Fig. 4A,
D). These observations could indicate that iNoLSs do not interact equally
with any nuclear RNA but interact preferentially with nucleolar RNA
from B23-containing ribonucleoprotein complexes. To verify this hy-
pothesis, we used bimolecular ﬂuorescence complementation (BiFC),
which reveals the proximity of molecules. This technique is more sensi-
tive than the Förster resonance energy transfer (FRET) method [54,55].
Plasmids encoding YFP fragments (nYFP and cYFP) fused with either
R19 or B23 were constructed. To reduce the possibility that interactions
would not be detected, two types of B23-coding constructs were
created, in which the localization of YFP fragments occurred at the
N- or C-terminus of B23 (n/cYFP-B23 and B23-n/cYFP, respectively).
Wewere unable to detect any ﬂuorescence after the coexpression of
the pairs nYFP/cYFP, nYFP/cYFP-R19, nYFP/cYFP-B23, nYFP/B23-cYFP,
cYFP/nYFP-R19, cYFP/nYFP-B23 or cYFP/B23-nYFP, indicating the
absence of non-speciﬁc associations mediated by YFP fragments. BiFC
ﬂuorescence was detected in the transfected cells for all pairs of
coexpressed fusion proteins presented in Fig. 5H. The highest ﬂuores-
cence level was observed when both coexpressed proteins contained
B23 either on the N- or on the C-terminal end of the fused molecules
(pairs: nYFP-B23/cYFP-B23 and B23-nYFP/B23-cYFP). This ﬁnding may
be explained by the ability of B23 molecules to form homodimers
through interactions between N-end domains [56]. When the YFP frag-
mentswere fused on the opposite ends of B23 (the pairs nYFP-B23/B23-
cYFP and B23-nYFP/cYFP-B23), a few cells with dim ﬂuorescence were
observed.
Weak but distinct ﬂuorescence was visible in the nucleoli for all
coexpressions of R19 and B23 fused with YFP fragments (pairs: nYFP-
R19/cYFP-B23, nYFP-R19/B23-cYFP, cYFP-R19/nYFP-B23 and cYFP-
R19/B23-nYFP), indicating that these proteins were indeed localized
in close proximity to one another.
4. Discussion
4.1. Approach
NoLSs are a highly heterogeneous group of sequences, and different
approaches have been used to map them. The major complication in-
volved in investigating NoLSs is that there might be several interaction
Fig. 5. EGFP-19 interacts with nucleolar RNAs rather than with B23. (A) Cells treated with 20 μg/ml actinomycin D did not include 5-ethynyl uridine (EU), which indicated the total
inhibition of RNA transcription. (B) In cells treated with 20 μg/ml actinomycin D, the B23 content was not changed signiﬁcantly (immunoblotting with the antibody against B23). The
β-tubulin was detected as a loading control. (C) In cells treated with 20 μg/ml actinomycin D, EGFP-R19 was localized in the nucleoplasm and in nucleoplasmic bodies. These bodies in-
cluded RNA,whichwas labeledwith EU. (D) The EGFP-R19 bodies did not contain B23. (E) B23 depletion by shRNA (β-tubulinwas detected as a loading control). (F) The depletion of B23
did not lead to the removal of EGFP-R19 from the nucleoli. The NoLS activity was not signiﬁcantly changed by the expression of the control or of B23-speciﬁc shRNAs (the error bars
represent S.D.). (G) The interaction of puriﬁed EGFP and EGFP-R19with permeabilized cells (in situ). EGFP-R19 interactedwith the nucleoli of the control cells or the nucleoplasmic bodies
of cells treated with 20 μg/ml actinomycin D in an RNase-sensitive manner, both in the control and in cells after B23 depletion with shRNA. The cells were registered under identical
conditions, and the images were processed equally. (H) Bimolecular ﬂuorescence complementation indicates that EGFP-R19 resists in close proximity to B23 in the nucleoli of living
cells. The cells were registered under identical conditions, and the images were processed identically. Scale bars = 5 μm.
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make it difﬁcult to identify the NoLS activity, especially if this activity
is not very strong. For example, a NoLSwas recently found in GNL1 pro-
tein,which is capable of accumulating EGFP in the nucleoli [57]. Howev-
er, themajor role of this protein's accumulation in the nucleoli is played
by another part of the protein (G-domain). Therefore, itwas particularly
important to estimate the NoLS activities using a system in which the
NoLS activity would not be inﬂuenced by different protein regions.
Here, we used an approach based on the analysis of a tested sequence
as a factor in the nucleolar accumulation of a ﬂuorescentmarker protein
(EGFP).4.2. Charge-dependent accumulation of nucleolar proteins
We have described a possible mechanism through which some
NoLSs may be assisted in the dynamic accumulation of proteins inside
nucleoli. The three groups of observations provide evidence favoring
the hypothesis that this accumulation results from a charge-
dependent rather than a sequence-speciﬁc mechanism. (i) The speciﬁc-
ity of action for many known signals (e.g., the nuclear localization
signal) is associated with their particular structure, which allows them
to interact precisely with import machinery [58]. NoLSs are enriched
with positively charged amino acids, but it is not possible to identify a
109Y.R. Musinova et al. / Biochimica et Biophysica Acta 1853 (2015) 101–110consensus sequence. Perhaps the mechanism of action of this signal is
charge-dependent, but it does not depend on a speciﬁc amino acid
sequence. (ii) In two analyzed proteins (NIK and HIV-1 Tat), the NoLSs
correspond to a region that is enriched for positively charged amino
acid residues. The replacement of charged amino acids (R and K) with
glycine (G) reduced the nucleolar accumulation in proportion to the
charge reduction. A strong correlation between the charge of the tested
sequence and the efﬁciency of nucleolar accumulation was observed.
(iii) The lysine or arginine-enriched sequences (iNoLSs) were accumu-
lated in the nucleoli in a charge-dependentmanner. A strong correlation
was observed between the charge and nucleolar accumulation of EGFP
fused with iNoLS. Furthermore, we found that a clustering of charged
amino acids promoted more effective nucleolar accumulation.
Thus, the positively charged regions of the protein promote the ac-
cumulation of proteins in the nucleoli through a charge-dependent
(electrostatic) mechanism. It is doubtful that this mechanism could be
extremely speciﬁc, as each charged region can potentially act as an
NoLS. This phenomenon could explain the usual overlapping of NoLSs
with different functional domains, for example, with classical nuclear
localization signals [19,59].4.3. The interaction of charged protein regions with RNA leads to protein
accumulation in the nucleolus
The results of the current work demonstrate that positively charged
regions can potentially serve as functional NoLSs for protein accumula-
tion inside nucleoli via interactionwith RNA rather thanwith B23. In the
latter case, B23 (or other proteins) might be proposed as receptors for
speciﬁc signals. The mechanism described here, namely the interaction
with nucleolar RNAs, is different in principle, and it is also highly differ-
ent from the mechanisms of action for other known signals (which in-
clude a nuclear localization signal, a signal sequence for mitochondrial
import and an endoplasmic reticulum signal sequence, among others)
that interactwith speciﬁc receptors. In addition, the nucleolar detention
signals, or NoDSs, have a very distinct consensus sequence and are re-
sponsible for protein immobilization inside nucleoli after heat shock
or acidic and transcriptional stresses on speciﬁc non-coding RNAs [60].
It appears that interaction of positively charged regions with RNA
cannot be highly speciﬁc. Recently, it was demonstrated that a basic,
intrinsically disordered region of B23 strongly associates with RNA
with low speciﬁcity [61]. Additionally, nucleolar accumulation of topo-
isomerase IIβ involves tethering events with RNA through the interac-
tion with two short regions of topoisomerase IIβ enriched with
positively charged amino acids [62]. Using an in vitro RNA-binding
assay, it was demonstrated that topoisomerase IIβ interacts with both
poly(A)− RNA and poly(A)+ RNA isolated from HEK cells, indicating
low speciﬁcity of RNA binding [62]. However, it is possible that RNA
binding may be more speciﬁc in living cells, inside which the charge of
some RNAs may be partially neutralized by the RNA-binding proteins.4.4. A possible biological role for nucleolar accumulation via
charged regions
The functioning of biological molecules is accompanied by the tem-
poral association of thesemolecules at their functional locations. Here, it
was demonstrated that charged regions, which function as NoLSs, may
accumulate EGFP within nucleoli and thus locally enhance the protein
concentrations. EGFP-R19 is unlikely to have any function in nucleoli;
however, such activity-independent bindingmight lead to protein accu-
mulation in nucleoli. In the case of nucleolar proteins with additional
sites for activity-dependent binding, accumulation via NoLSs may
increase the probability of interaction between this protein and the
functional sites within the nucleoli. Thus, dynamic binding via charged
regionsmay enhance the functional efﬁciency of the nucleolar proteins.Acknowledgments
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